DOP2010000156A - Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca - Google Patents
Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiacaInfo
- Publication number
- DOP2010000156A DOP2010000156A DO2010000156A DO2010000156A DOP2010000156A DO P2010000156 A DOP2010000156 A DO P2010000156A DO 2010000156 A DO2010000156 A DO 2010000156A DO 2010000156 A DO2010000156 A DO 2010000156A DO P2010000156 A DOP2010000156 A DO P2010000156A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- treatment
- oxazolidinones
- profilaxis
- cardiac insufficiency
- heart failure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion se refiere al use de inhibidores selectivos del factor de coagulacion Xa, en particular de oxazolidinonas de la formula (I), para el tratamiento y/o profilaxis de la insuficiencia cardiaca y/o trastornos relacionados con la insuficiencia cardiaca asi como a su use para la preparacion de farmacos para el tratamiento y/o profilaxis de la insuficiencia cardiaca y/o trastornos relacionados con la insuficiencia cardiaca.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US740607P | 2007-12-11 | 2007-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2010000156A true DOP2010000156A (es) | 2011-02-15 |
Family
ID=40404481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2010000156A DOP2010000156A (es) | 2007-12-11 | 2010-05-25 | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca |
Country Status (18)
Country | Link |
---|---|
US (1) | US20110003804A1 (es) |
EP (1) | EP2229173A1 (es) |
JP (1) | JP2011506363A (es) |
KR (1) | KR20110010689A (es) |
CN (1) | CN101896185A (es) |
AU (1) | AU2008335922A1 (es) |
BR (1) | BRPI0820964A2 (es) |
CA (1) | CA2708418C (es) |
DO (1) | DOP2010000156A (es) |
IL (1) | IL205675A (es) |
MA (1) | MA31902B1 (es) |
MX (1) | MX2010005545A (es) |
NZ (1) | NZ586002A (es) |
RU (2) | RU2494740C2 (es) |
SV (1) | SV2010003578A (es) |
TN (1) | TN2010000266A1 (es) |
UA (1) | UA99638C2 (es) |
WO (1) | WO2009074249A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2905760T3 (es) * | 2009-07-31 | 2022-04-12 | Krka D D Novo Mesto | Procedimientos para la cristalización del rivaroxabán |
CN103626749A (zh) * | 2012-08-21 | 2014-03-12 | 苏州泽璟生物制药有限公司 | 取代的噁唑烷酮化合物和包含该化合物的药物组合物及其用途 |
JP2020524283A (ja) * | 2017-06-20 | 2020-08-13 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 急性非代償性心不全(adhf)患者が凝固亢進状態を示すかどうかを同定するための方法 |
TWI816712B (zh) * | 2017-11-09 | 2023-10-01 | 國立大學法人東京醫科齒科大學 | 癌促進因子表現抑制劑的有效成分之篩選用試藥及其篩選方法、癌之預防或治療劑的有效成分之篩選用試藥及其篩選方法、癌促進因子表現抑制劑及癌之預防或治療劑 |
JP6574041B2 (ja) * | 2017-12-15 | 2019-09-11 | エルメッド株式会社 | リバーロキサバン含有医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993009103A1 (en) * | 1991-11-01 | 1993-05-13 | The Upjohn Company | Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents |
DK0623615T3 (da) * | 1993-05-01 | 1999-12-13 | Merck Patent Gmbh | Adhæsionsreceptor-antagonister |
DE19962924A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
TW200812619A (en) * | 2006-04-06 | 2008-03-16 | Schering Corp | TRA combination therapies |
-
2008
- 2008-12-03 EP EP08860784A patent/EP2229173A1/en not_active Withdrawn
- 2008-12-03 CA CA2708418A patent/CA2708418C/en not_active Expired - Fee Related
- 2008-12-03 NZ NZ586002A patent/NZ586002A/en not_active IP Right Cessation
- 2008-12-03 MX MX2010005545A patent/MX2010005545A/es active IP Right Grant
- 2008-12-03 JP JP2010537292A patent/JP2011506363A/ja active Pending
- 2008-12-03 BR BRPI0820964-2A patent/BRPI0820964A2/pt not_active IP Right Cessation
- 2008-12-03 CN CN2008801209375A patent/CN101896185A/zh active Pending
- 2008-12-03 US US12/746,661 patent/US20110003804A1/en not_active Abandoned
- 2008-12-03 RU RU2010128442/15A patent/RU2494740C2/ru not_active IP Right Cessation
- 2008-12-03 WO PCT/EP2008/010211 patent/WO2009074249A1/en active Application Filing
- 2008-12-03 AU AU2008335922A patent/AU2008335922A1/en not_active Abandoned
- 2008-12-03 UA UAA201008619A patent/UA99638C2/ru unknown
- 2008-12-03 KR KR1020107012797A patent/KR20110010689A/ko not_active Application Discontinuation
-
2010
- 2010-05-11 IL IL205675A patent/IL205675A/en unknown
- 2010-05-25 DO DO2010000156A patent/DOP2010000156A/es unknown
- 2010-05-26 SV SV2010003578A patent/SV2010003578A/es unknown
- 2010-06-08 MA MA32895A patent/MA31902B1/fr unknown
- 2010-06-09 TN TN2010000266A patent/TN2010000266A1/fr unknown
-
2013
- 2013-07-22 RU RU2013134140/15A patent/RU2013134140A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20110003804A1 (en) | 2011-01-06 |
RU2010128442A (ru) | 2012-01-20 |
CA2708418C (en) | 2013-11-12 |
JP2011506363A (ja) | 2011-03-03 |
EP2229173A1 (en) | 2010-09-22 |
BRPI0820964A2 (pt) | 2015-07-14 |
CA2708418A1 (en) | 2009-06-18 |
KR20110010689A (ko) | 2011-02-07 |
SV2010003578A (es) | 2011-02-21 |
NZ586002A (en) | 2012-06-29 |
IL205675A0 (en) | 2010-11-30 |
UA99638C2 (ru) | 2012-09-10 |
MA31902B1 (fr) | 2010-12-01 |
IL205675A (en) | 2013-10-31 |
CN101896185A (zh) | 2010-11-24 |
RU2494740C2 (ru) | 2013-10-10 |
TN2010000266A1 (en) | 2011-11-11 |
WO2009074249A1 (en) | 2009-06-18 |
MX2010005545A (es) | 2010-07-30 |
RU2013134140A (ru) | 2015-01-27 |
AU2008335922A1 (en) | 2009-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
ECSP088358A (es) | Tratamiento y profilaxis de microangiopatías | |
CU20140141A7 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas | |
ECSP077296A (es) | Fenilaminotiazoles sustituidos y su uso | |
DOP2009000287A (es) | Oxazolidinonas sustituidas y su uso | |
ECSP10010494A (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa | |
CU20090216A7 (es) | (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea | |
BR112012013487A2 (pt) | Composições de amantadina e métodos de uso | |
CU20100111A7 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares | |
ECSP099518A (es) | Uso de derivados de ácido de piranona sustituidos para el tratamiento del síndrome metabólico | |
GT201300125A (es) | 1h-pirazol-5-olato sódico sustituido | |
ECSP11011483A (es) | Piperidinas sustituidas | |
DOP2010000156A (es) | Oxazolidinonas para el tratamiento y/o profilaxis de la insuficiencia cardiaca | |
UY31717A1 (es) | (pirazolilcarbonil) imidazolidinonas sustituidas y su uso | |
UA108975C2 (uk) | Застосування співполімеру натрійкарбоксиметилцелюлози і госиполу в комплексній терапії пацієнтів з аутистичними розладами і когнітивними порушеннями | |
CR20110627A (es) | Piperidinas sustituidas | |
CL2009001006A1 (es) | Compuestos derivados del acido 4-dimetil-aminobutirico; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de enfermedades tales como hiperglucemia, diabetes e hipertension entre otras. | |
PE20090314A1 (es) | DERIVADOS DE OXAZOLIDINONA COMO AGENTES INHIBIDORES DE LA TROMBINA Y EL FACTOR Xa | |
UY30586A1 (es) | Derivados de tartrato como inhibidores del factor de coagulacion ixa | |
DOP2005000174A (es) | Fenilaminotiazoles sustituidos y su uso | |
CL2011002626A1 (es) | Compuestos derivados de piperazina, como antagonistas del receptor p2y12; composicion farmaceutica que los contienen; y su uso en el tratamiento de trastornos vasculares oclusivos. | |
CU20100183A7 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa | |
CU23534B7 (es) | Nuevos derivados de 4-bencilidenpiperidina | |
RU2007140029A (ru) | Способ лечения хронической сердечной недостаточности |